Powered by Blogger.
Showing posts with label marketing. Show all posts
Showing posts with label marketing. Show all posts

Pfizer's Umpteenth Settlement (for $491 Million Plus a Guilty Plea), but No Person Held Responsible

thumbnail The world's largest research based pharmaceutical company was in court again, as reported by the New York Times,  The drug maker Pfizer...

Shut Up and Sell - the Corporate Physician's New Motto?

thumbnail Evidence has been seeping into public view about the extent physicians who sign up to take care of patients as corporate employees give up ...

Doctors' Dubious Excuses for Taking Pharmaceutical Companies' Money

thumbnail Pro Publica has updated their database of payments by pharmaceutical payments to physicians and organizations.  It now has data from 15 comp...

The Dangers of Big Corporate Health Care: Deceptive Marketing of Cancer Treatments

thumbnail A series of articles over the last few months, culminating in an investigative report by Reuters, provided the newest example of what can go...

Oh, the Prices we Pay ... for Questionable Drug Marketing to Enrich Corporate Insiders - the Case of Questcor's H P Acthar Revisited

thumbnail In 2007, we first discussed the case of the amazing pricing of H P Acthar, a very old drug of questionable usefulness, as an example of the...

'Tis the Season for Legal Settlements: GlaxoSmithKline, Eli Lilly, Orthofix, Sanofi all Settle

thumbnail Reports of legal settlements by big health care organizations tend to dribble out towards the end of the year, maybe in a rush to finalize t...